Related Experiment Video
Updated: May 7, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Forewarned is forearmed: erythropoietin use in CKD patients with cancer
Samuel J Kessler1, Charles L Bennett
1South Carolina College of Pharmacy, Columbia, South Carolina - USA.
Abstract:
Nayak-Rao and McCormick raise important concerns about erythropoietin use in patients with chronic kidney disease and cancer, and appropriately build a case for caution in this setting (J Nephrol. 2013, in press). Their comprehensive and insightful review highlights both the clinical and the basic science considerations that form the basis for this warning.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Chronic Kidney Disease IV: Nursing Management